Table 2.
Laboratory results of 100 COVID-19 cases in Taiwan.
| Laboratory results within 48 h of admission (number of cases with data available) | Median (interquartile range)/Number (%) of patients |
|---|---|
| Total white blood cell count (103/uL) (n = 62) | 5.7 (4.2–6.9) |
| <4 | 12 (19.4) |
| 4-10 | 48 (77.4) |
| >10 | 2 (3.2) |
| Lymphocyte count (103/uL) (n = 56) | 1.2 (0.9–1.9) |
| <1 | 18 (32.1) |
| Hemoglobin (g/dL) (n = 60) | 14.3 (13.2–14.8) |
| <10 | 2 (3.3) |
| Platelet count (103/uL) (n = 60) | 208.5 (174.8–266.0) |
| <100 | 2 (3.3) |
| Blood urea nitrogen (mg/dL) (n = 40) | 14.1 (11.0–15.0) |
| >20 | 2 (5.0) |
| Serum creatinine (mg/dL) (n = 58) | 0.8 (0.6–0.9) |
| >1.3 | 3 (5.2) |
| Aspartate aminotransferase, AST (U/L) (n = 45) | 25.0 (19.0–33.8) |
| >40 | 8 (17.8) |
| Alanine aminotransferase, ALT (U/L) (n = 43) | 23.0 (15.0–31.0) |
| >40 | 5 (11.6) |
| C-reactive protein, CRP (mg/dL) (n = 50) | 0.6 (0.2–1.5) |
| >1 | 19 (38.0) |
| Lactate dehydrogenase, LDH (U/L) (n = 27) | 218.0 (150.0–265.0) |
| >245 | 10 (37.0) |
| Creatine kinase, CK (U/L) (n = 15) | 78.0 (45.0–165.0) |
| >185 | 3 (20.0) |
| D-dimer (ng/mL) (n = 5) | 238.0 (190.0–1064.5) |
| >500 | 2 (40.0) |
| Procalcitonin (ng/mL) (n = 9) | 0.058 (0.046–0.115) |
| >0.5 | 0 (0) |